Haemonetics Corporation ( HAE) - Key Metrics
HAE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $7.48 | $0.73 | $1.15 | $0.98 |
| 2026Q4 | $7.49 | -$0.44 | $1.53 | $1.15 |
| 2026Q3 | $7.24 | $0.96 | $2 | $1.86 |
| 2026Q2 | $6.88 | $0.81 | $2.34 | $2.23 |
| 2026Q1 | $6.68 | $0.71 | $0.36 | $0.28 |
HAE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | 26.47 |
| 2026Q4 | 0% | -30.70 |
| 2026Q3 | 0% | 20.91 |
| 2026Q2 | 0% | 14.87 |
| 2026Q1 | 0% | 25.99 |
HAE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2027Q1 | 1.27% | 0% |
| 2026Q4 | 2.13% | 0% |
| 2026Q3 | 2.32% | 0% |
| 2026Q2 | 4.64% | 0% |
| 2026Q1 | 0.38% | 0% |
HAE
Price: $121.11
52 week price:
Earnings Per Share: 2.16 USD
P/E Ratio: 42.29
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 121503
Ebitda: 23.3 millionMarket Capitalization: 4.7 billion